Principal Investigator
Khema Sharma
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20201512
Clinical Trial Summary
A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ADHERE)
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Other